JAIN, S. et al. Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. Academia Journal of Medicine, v. 9, n. 2, p. 201–205, 23 Oct.2026.